K2 Principal Fund’s UROPLASTY INC-NEW UPI Stock Holding History

K2 Principal Fund’s Portfolio UPI Stock Details UPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-25,000	Closed	-$52K	–	219
2014 Q4	$52K	Buy	+25,000	New	+$59.4K	0.01%	155

Other funds holding UPI

Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RCP

Rothschild Capital Partners New York $408M AUM 25.87% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

K2 Principal Fund's UPI Position: Q1 2015 in Review

K2 Principal Fund sold out of UROPLASTY INC-NEW (UPI) in Q1 2015, closing a stake of 25,000 shares — an estimated $52K sold.

K2 Principal Fund first reported a position in UPI in Q4 2014 and held it in 1 quarter. The position peaked at $52K in Q4 2014. 31 funds tracked by Wall St. Rank hold UPI as of Q1 2015.

K2 Principal Fund reported no remaining UROPLASTY INC-NEW position as of Q1 2015 after selling out during the quarter.
K2 Principal Fund sold 25,000 UROPLASTY INC-NEW shares in Q1 2015, an estimated $52K.
K2 Principal Fund first reported a position in UROPLASTY INC-NEW in Q4 2014 and held it in 1 quarter.
K2 Principal Fund's UROPLASTY INC-NEW position peaked at $52K in Q4 2014.
31 funds tracked by Wall St. Rank held UROPLASTY INC-NEW as of Q1 2015.

Based on K2 Principal Fund's 13F filing for Q1 2015, filed 30 Apr 2015.